Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors.
AUTOR(ES)
Baethge, B A
RESUMO
A patient with scleroderma renal disease and pulmonary hypertension who had a successful pregnancy with the use of angiotensin converting enzyme inhibitors is presented. The routine use of these inhibitors during pregnancy is not recommended, however, owing to the reported potential risks to the fetus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1003873Documentos Relacionados
- Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors.
- Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
- Lung angiotensin converting enzyme activity in rats with pulmonary hypertension.
- Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension.
- Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors.
